Lymphomatous meningitis: Early diagnosis and treatment

Clinical Journal of Oncology Nursing

Volumn 13, Issue 1, 2009, Pages 90-94

  van Horn, Alixis ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM TUMOR; EARLY DIAGNOSIS; HUMAN; MENINGIOMA; METASTASIS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

BRAIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; EARLY DIAGNOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGEAL NEOPLASMS;

EID: 70349254355     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/09.CJON.90-94     Document Type: Article

References (21)

1. Berg, S.L., & Chamberlain, M.C. (2003). Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis. Current Oncology Reports, 5(1), 29-40.
2. Bierman, P., & Giglio, P. (2005). Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. Hematology/Oncology Clinics of North America, 19(4), 597-609.
3. Chamberlain, M. (2006). Lymphomatous meningitis in primary centralnervous system lymphoma. Neurosurgical Focus, 21(5), 6.
4. Chamberlain, M.C., & Kormanik, P.A. (1997). Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Archives of Neurology, 54(11), 1364-1368.
5. Chamberlain, M.C., Kormanik, P.A., & Barba, D. (1997). Complications associated with intraventricular chemotherapy in patientswith leptomeningeal metastases. Journal of Neurosurgery, 87(5), 694-699.
6. Cole, B.F., Glantz, M.J., Jaeckle, K.A., Chamberlain, M.C., & Mackowiak, J.I. (2003). Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis. Cancer, 97(12), 3053-3060.
7. Craig, C. (2000). Current treatment approaches for neoplastic meningitis: Nursing management of patients receiving intrathecal DepoCyt. Oncology Nursing Forum, 27(8), 1225-1230.
8. Davson, H. (1967). Physiology of the cerebrospinal fluid. London: Churchill.
9. Demopoulos, A. (2004). Leptomeningeal metastases. Current Neurology and Neuroscience Reports, 4(3), 196-204.
10. Drappatz, J., & Batchelor, T.T. (2007). Leptomeningeal neoplasms. Current Treatment Options in Neurology, 9(4), 283-293.
11. Dyken, P.R. (1975). Cerebrospinal fluid cytology: Practical clinical usefulness. Neurology, 25(3), 210-217.
12. Glantz, M.J., LaFollette, S., Jaeckle, K.A., Shapiro, W., Swinnen, L., Rozental, J.R., et al. (1999). Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. Journal of Clinical Oncology, 17(10), 3110-3116.
13. Gleissner, B., & Chamberlain, M.C. (2006). Neoplastic meningitis. Lancet Neurology, 5(5), 443-452.
14. Gleissner, B., & Chamberlain, M.C. (2007). Treatment of CNS dissemination in systemic lymphoma. Journal of Neuro-Oncology, 84(1), 107-117.
15. Jaeckle, K.A. (2006). Neoplastic meningitis from systemic malignancies: Diagnosis, prognosis and treatment. Seminars in Oncology, 33(3), 312-323.
16. Kim, L., & Glantz, M.J. (2001). Neoplastic meningitis. Current Treatment Options in Oncology, 2(6), 517-527.
17. McComb, J.G. (1983). Recent research into the nature of cerebrospinal fluid formation and absorption. Journal of Neurosurgery, 59(3), 369-383.
18. Murry, D.J., & Blaney, S.M. (2000). Clinical pharmacology of encapsulated sustained-release cytarabine. Annals of Pharmacotherapy, 34(10), 1173-1178.
19. National Comprehensive Cancer Network. (2008). Clinical Practice Guidelines in Oncology™. Central nervous system cancers [v.1.2008]. Retrieved December 10, 2008, from http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf
20. Rueda Dominguez, A., Olmos Hidalgo, D., Viciana Garrido, R., & Torres Sanchez, E. (2005). Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis. Clinical and Translational Oncology, 7(6), 232-238.
21. Seehusen, D.A., Reeves, M.M., & Fomin, D.A. (2003). Cerebrospinal fluid analysis. American Family Physician, 68(6), 1103-1108.